Patent · US Active

Di-azetidinyl diamide as monoacylglycerol lipase inhibitors

US8759333B2 · kind B2 · utility

44Cited by

0References

2Claims

0Family size

Assignee

Janssen Pharmaceuticals, Inc. · BE

Inventors

Peter J. Connolly · New Providence, US
Mark J. Macielag · Spring House, US
Bin Zhu · Spring House, US

Key dates

Filing date	Mar 13, 2013
Grant date	Jun 24, 2014
Priority date	—
Expiry date	Mar 13, 2033

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D513/04
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Disclosed are compounds, compositions and methods for treating various diseases, syndromes, conditions and disorders, including pain. Such compounds are represented by Formula (I) as follows:wherein Q and Z are defined herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.